Mouse Monoclonal Antibody to CDKN1A

Item Information
Catalog #
Size
Price
Description

This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene.

Product Overview
Entrez GenelD
1026
Aliases
P21; CIP1; SDI1; WAF1; CAP20; CDKN1; MDA-6; p21CIP1
Clone#
2B7F8
Host / Isotype
Mouse / IgG1
Immunogen
Purified recombinant fragment of human CDKN1A (AA: 1-164) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4℃; -20℃ for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
FCM (Flow Cytometry)
1/200 - 1/400
ELISA
1/10000
References
1.Cell Cycle. 2019 Apr;18(8):834-847. 2.Med Hypotheses. 2019 Dec;133:109414.
Product Image
Elisa
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Western Blot
Figure 2:Western blot analysis using CDKN1A mAb against human CDKN1A (AA: 1-164) recombinant protein. (Expected MW is 43.7 kDa)
Figure 2:Western blot analysis using CDKN1A mAb against human CDKN1A (AA: 1-164) recombinant protein. (Expected MW is 43.7 kDa)
Western Blot
Figure 3:Western blot analysis using CDKN1A mAb against HEK293-6e (1) and CDKN1A (AA: 1-164)-hIgGFc transfected HEK293-6e (2) cell lysate.
Figure 3:Western blot analysis using CDKN1A mAb against HEK293-6e (1) and CDKN1A (AA: 1-164)-hIgGFc transfected HEK293-6e (2) cell lysate.
Flow cytometric analysis
Figure 4:Flow cytometric analysis of K562 cells using CDKN1A mouse mAb (green) and negative control (red).
Figure 4:Flow cytometric analysis of K562 cells using CDKN1A mouse mAb (green) and negative control (red).
Immunohistochemical analysis
Figure 5:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using CDKN1A mouse mAb with DAB staining.
Figure 5:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using CDKN1A mouse mAb with DAB staining.
Immunohistochemical analysis
Figure 6:Immunohistochemical analysis of paraffin-embedded esophageal cancer tissues using CDKN1A mouse mAb with DAB staining.
Figure 6:Immunohistochemical analysis of paraffin-embedded esophageal cancer tissues using CDKN1A mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.